← Leaderboards
Attaya Suvannasankha
Rlr Va Medical Center
$0
Attributed
$0
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2014–24$1$1$1$0$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
VA$0 · 3
By mechanism
I01$0 · 3
Top collaborators
- John M Chirgwin8 shared
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesMultiple MyelomaOsteolyticOsteoblastsCellsOsteoclastsBoneOsteogenesisGrowthMouse ModelMalignant NeoplasmsTnfsf11 GeneProductionTumorBone DiseasesBone PainCell LineClinical TrialsTumor GrowthIncidenceResponseMetastatic Neoplasm To The BoneOsteocytesAutomobile Driving
Grant awards (10)
Preclinical Validation of Adjuvant Fingolimod to Increase Efficacy of Proteasome Inhibitors for Treatment of Multiple Myeloma$0
I01 · FY2024 · VA · contact PI
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity$0
I01 · FY2022 · VA
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity$0
I01 · FY2021 · VA
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity$0
I01 · FY2020 · VA
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity$0
I01 · FY2019 · VA
Role of Gfi-1 in Myeloma Bone Disease$0
I01 · FY2019 · VA · contact PI
Role of Osteocytes in Myeloma Bone Disease$0
I01 · FY2017 · VA
Role of Osteocytes in Myeloma Bone Disease$0
I01 · FY2016 · VA
Role of Osteocytes in Myeloma Bone Disease$0
I01 · FY2015 · VA
Role of Osteocytes in Myeloma Bone Disease$0
I01 · FY2014 · VA